Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$3,208 Mln
Revenue (TTM)
$158 Mln
Net Profit (TTM)
$0 Mln
ROE
-1.1 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
71.7
Industry P/E
--
EV/EBITDA
-9.4
Div. Yield
0 %
Debt to Equity
4.4
Book Value
$0.4
EPS
$-0.7
Face value
--
Shares outstanding
88,114,429
CFO
$-276.68 Mln
EBITDA
$-323.08 Mln
Net Profit
$-348.75 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Liquidia Technologies Inc (LQDA)
| 2.1 | 7.5 | -0.1 | 132.8 | 72.2 | 69.0 | -- |
|
BSE Sensex
| -12.5 | -11.1 | -13.4 | -3.7 | 8.5 | 8.2 | 11.3 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Liquidia Technologies Inc (LQDA)
| 193.3 | -2.2 | 88.9 | 30.8 | 65.1 | -31.0 | -80.3 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Liquidia Technologies Inc (LQDA)
|
35.2 | 3,208.3 | 158.3 | -68.9 | -29.3 | -113 | -- | 71.7 |
| 11.3 | 3,410.4 | 510.2 | 146.9 | 37.2 | 35.6 | 23.9 | 7.2 | |
| 12.1 | 3,722.1 | 3,018.8 | 72.1 | 12.6 | -80 | 53.8 | 86.1 | |
| 158.8 | 8,027.0 | 638.5 | -183.2 | -27.4 | -252.1 | -- | 92.0 | |
| 68.5 | 13,287.4 | 502.1 | -729.3 | -125.8 | 41.2 | -- | 123.7 | |
| 33.8 | 3,684.8 | 761.4 | 99.7 | 7.3 | 15 | 42.2 | 5.7 | |
| 24.9 | 11,922.1 | 4,715.0 | -232.0 | 0.9 | -3.7 | -- | 1.9 | |
| 7.6 | 7,645.3 | 7,227.1 | 386.1 | 16.6 | 6.9 | 13.8 | 0.9 | |
| 201.7 | 4,084.1 | 268.1 | 124.5 | 60.0 | 13.5 | 33.5 | 4.0 | |
| 62.0 | 2,932.6 | 1,103.8 | 186.5 | 27.9 | 10.1 | 15.8 | 1.6 |
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States. The company's lead product candidates include YUTREPIA, an inhaled dry powder... formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also provides Remodulin, a treprostinil injection administered through continuous intravenous and subcutaneous infusion; and develops L606, an investigational liposomal formulation of treprostinil which is in phase III clinical trial for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). In addition, the company offers PRINT technology which allows to engineer and manufacture uniform drug particles with precise control over the size, three-dimensional geometric shape, and chemical composition of the particles. It has a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD; Vectura; The University of North Carolina at Chapel Hill; GlaxoSmithKline; Alcon Inc; and promotion Agreement with Sandoz. Liquidia Corporation was founded in 2004 and is based in Morrisville, North Carolina. Read more
CEO & Director
Dr. Roger A. Jeffs Ph.D.
CEO & Director
Dr. Roger A. Jeffs Ph.D.
Headquarters
Morrisville, NC
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Liquidia Technologies Inc (LQDA) is $35.20 (NASDAQ) as of 24-Mar-2026 16:00 EDT. Liquidia Technologies Inc (LQDA) has given a return of 72.23% in the last 3 years.
Since, TTM earnings of Liquidia Technologies Inc (LQDA) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-50.07
|
77.12
|
|
2024
|
-7.64
|
12.89
|
|
2023
|
-10.06
|
16.70
|
|
2022
|
-9.74
|
4.42
|
|
2021
|
-7.19
|
3.81
|
The 52-week high and low of Liquidia Technologies Inc (LQDA) are Rs 46.67 and Rs 11.26 as of 25-Mar-2026.
Liquidia Technologies Inc (LQDA) has a market capitalisation of $ 3,208 Mln as on 20-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Liquidia Technologies Inc (LQDA), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$-0.30
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.